Status: retired, Primitive. Date: 28-Feb 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3740622012 | Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3740623019 | Hydralazine and isosorbide only product in oral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hydralazine and isosorbide only product in oral dose form | Is a | Hydralazine- and isosorbide-containing product in oral dose form | false | Inferred relationship | Some | ||
| Hydralazine and isosorbide only product in oral dose form | Has active ingredient | Isosorbide | false | Inferred relationship | Some | 1 | |
| Hydralazine and isosorbide only product in oral dose form | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| Hydralazine and isosorbide only product in oral dose form | Is a | Hydralazine and isosorbide only product | false | Inferred relationship | Some | ||
| Hydralazine and isosorbide only product in oral dose form | Has active ingredient | Hydralazine | false | Inferred relationship | Some | 2 | |
| Hydralazine and isosorbide only product in oral dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hydralazine 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Is a | False | Hydralazine and isosorbide only product in oral dose form | Inferred relationship | Some | |
| Hydralazine hydrochloride 37.5 mg and isosorbide dinitrate 20 mg oral tablet | Is a | False | Hydralazine and isosorbide only product in oral dose form | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
ALTERNATIVE association reference set
FHIR